Carclo Engineering Plc CCEGF

$0.67 -0.17 (-20.36%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
5,000
Avg volume
—
Day's range
$0.67 – $0.67
Shares out
—
Stochastic %K
—
Beta
—
Analysts
—
Price target
—

Price

Company profile

Carclo plc, together with its subsidiaries, operates as a plastics company in the United Kingdom, the rest of Europe, North America, and internationally. It operates in two segments, CTP and Speciality. The company offers in vitro diagnostics and medical devices, such as sample tips and probe tips, cuvettes and multi-well components, single-use cartridges and assay consumables, and ancillary parts for automation and...

Show more

Carclo plc, together with its subsidiaries, operates as a plastics company in the United Kingdom, the rest of Europe, North America, and internationally. It operates in two segments, CTP and Speciality. The company offers in vitro diagnostics and medical devices, such as sample tips and probe tips, cuvettes and multi-well components, single-use cartridges and assay consumables, and ancillary parts for automation and fluid handling; and components and assemblies for a range of drug delivery devices, including inhalers, auto-injectors and associated delivery systems. It also provides FusionCap, a vial closure concept; PureStop, a driving stopper engagement; GuardVial, a polymer vial; flight-control and low-stretch cables, streamline wires, and cable assembly and test; and CNC turning and milling, thread rolling, fixtures and small assemblies, and rapid specials for race programs. In addition, the company offers safety systems, arrestor gear ropes, inspection and life-cycle support, and rescue winch cables; and safety and security solutions. Carclo plc was incorporated in 1924 and is based in Mitcham, the United Kingdom.

Industry
Auto Parts
Sector
Consumer Cyclical
Phone
44 20 8685 0500
Website
https://www.carclo.co.uk
Address
47 Wates Way, Mitcham, United Kingdom

Latest news

No headlines yet.